Clinical Diagnostics

Selected news for the healthcare topic - Clinical Diagnostics, collected since 10/2017. This healthcare topic shares news with COVID-19, Infectious Disease, Siemens, Thermo Fisher, Genomics and hundreds of others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
1/20/2022 Ortho Clinical Diagnostics Holdings plc (NASDAQ:OCDX) Shares Sold by Victory Capital Management Inc. - Transcript Daily transcriptdaily.com Victory Capital Management Inc. trimmed its holdings in Ortho Clinical Diagnostics Holdings plc (NASDAQ:OCDX) by 4.7% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 11,287 shares of the company’s stock after selling 558 shares during the quarter. Victory Capital Management Inc.’s holdings in Ortho Clinical Diagnostics were worth $209,000 as of its most recent filing ...
1/20/2022 Victory Capital Management Inc. Has $209,000 Stake in Ortho Clinical Diagnostics Holdings plc (NASDAQ:OCDX) - Stock Observer thestockobserver.com Victory Capital Management Inc. trimmed its holdings in Ortho Clinical Diagnostics Holdings plc (NASDAQ:OCDX) by 4.7% in the third quarter, Holdings Channel reports. The fund owned 11,287 shares of the company’s stock after selling 558 shares during the period. Victory Capital Management Inc.’s holdings in Ortho Clinical Diagnostics were worth $209,000 at the end of the most recent quarter.A number of other large investors have also ...
1/18/2022 Diagnostics pioneers Abacus Diagnostica, Kaivogen and Labrox are now together Uniogen cision.com ... development for point-of-care testing for infectious diseases and cancers, among others.Although Uniogen is new as a company, the underlying companies, Abacus Diagnostica, Kaivogen and Labrox, have years of experience in international clinical diagnostics and life science markets. In 2021, the combined annual net sales of the three companies forming Uniogen was approximately EUR 15 million. The company is profitable and cash flow positive. Uniogen's products are sold ...
1/18/2022 Diagnostics pioneers Abacus Diagnostica, Kaivogen and Labrox are now together Uniogen PR Newswire ... development for point-of-care testing for infectious diseases and cancers, among others.Although Uniogen is new as a company, the underlying companies, Abacus Diagnostica, Kaivogen and Labrox, have years of experience in international clinical diagnostics and life science markets. In 2021, the combined annual net sales of the three companies forming Uniogen was approximately EUR 15 million . The company is profitable and cash flow positive. Uniogen's products are sold ...
1/17/2022 Aiforia appoints VP of Sales, Americas cision.com Aiforia appoints VP of Sales, AmericasIncoming VP brings over 20 years experience in the healthcare industry to help accelerate further business growth at Aiforia.Aiforia, a technology company providing deep learning AI software for image analysis in pathology in clinical diagnostics and preclinical analysis, today announced that Marco Comianos has joined the company as VP of Sales, Americas. Comianos will oversee sales efforts, as well as driving new business ...
1/15/2022 Halper Sadeh LLP Investigates FLMN, VCRA, ADTX, OCDX; Globe Newswire ... VoceraAditxt Inc. (NASDAQ: ADTX) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with AiPharma Global Holdings LLC. If you are a AditxtOrtho Clinical Diagnostics Holdings plc (NASDAQ: OCDX) Quidel Corporation. proposed agreement, Ortho $7.14 in cash per common share and 0.1055 shares of common stock in the combined company for each Ortho common share, with Ortho shareholders expected ...
1/15/2022 Halper Sadeh LLP Investigates FLMN, VCRA, ADTX, OCDX; Shareholders are Encouraged to Contact the Firm forextv.com ... securities laws and/or breaches of fiduciary duties relating to its merger with AiPharma Global Holdings LLC. If you are a Aditxt shareholder, click here to learn more about your rights and options.Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Quidel Corporation. Under the terms of the proposed agreement, Ortho shareholders ...
1/11/2022 Ortho Clinical Diagnostics (NASDAQ:OCDX) Issues FY21 Earnings Guidance - Ticker Report Ticker Report Ortho Clinical Diagnostics (NASDAQ:OCDX) updated its FY21 earnings guidance on Tuesday. The company provided EPS guidance of $0.76-0.78 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.77. The company issued revenue guidance of $2.00-2.02 billion, compared to the consensus revenue estimate of $2.04 billion.A number of research firms have commented on OCDX. Barclays cut shares of Ortho Clinical Diagnostics from an overweight rating to ...
1/11/2022 Ortho Clinical Diagnostics (NASDAQ:OCDX) Releases FY21 Earnings Guidance Daily Political Ortho Clinical Diagnostics (NASDAQ:OCDX) updated its FY21 earnings guidance on Tuesday. The company provided EPS guidance of $0.76-0.78 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.77. The company issued revenue guidance of $2.00-2.02 billion, compared to the consensus revenue estimate of $2.04 billion.Several equities research analysts have recently weighed in on the company. Zacks Investment Research downgraded Ortho Clinical Diagnostics from a buy rating ...
1/11/2022 Ortho Clinical Diagnostics (NASDAQ:OCDX) Updates FY21 Earnings Guidance - Slater Sentinel slatersentinel.com Ortho Clinical Diagnostics (NASDAQ:OCDX) issued an update on its FY21 earnings guidance on Tuesday morning. The company provided earnings per share guidance of $0.76-0.78 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.77. The company issued revenue guidance of $2.00-2.02 billion, compared to the consensus revenue estimate of $2.04 billion.Shares of NASDAQ OCDX opened at $20.63 on Tuesday. The company has a ...
1/10/2022 Cell Expansion Technologies Market Size 2022: In-Depth Players Analysis, Industry Trends, Share, Growth, Supply Demand Scenario and Regional Forecast till 2028 themarketpublicist.com ... each product type?- How much is the sales estimates as well as projected valuation of every product segment in the industry by the end of the projected timeframe?- Which of the various application spanning Clinical diagnostics, Drug discovery and development, Regenerative medicine and Others may emerge to be a highly profitable vertical in the Cell Expansion Technologies market?- How much share does each application account for in the Cell Expansion ...
1/10/2022 SHAREHOLDER ALERT: WeissLaw LLP Investigates Ortho Clinical Diagnostics Holdings plc icrowdnewswire.com Advertising Driven Press Release DistributionWeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Ortho Clinical Diagnostics Holdings plc, in connection with the proposed acquisition of the Company by Quidel Corporation. Under the terms of the merger agreement, the Company’s shareholders will receive $7.14 in cash and 0.1055 shares of common stock in the combined company for each ...
1/10/2022 Apple silicon head Jeff Wilcox joins Intel indusbusinessjournal.com ... the last eight of those years, Wilcox led that system architecture team in multiple roles, most recently as the company’s director of Mac system architecture.Wilcox began his career in 1994 with Ortho Clinical Diagnostics as a Design Engineer. In 1997, he became Principal Component Architect for Intel Corp.Ten years later he transitioned to being Principal Architect for NVIDIA, only to return to Intel as the Principal Engineer ...
1/9/2022 Halper Sadeh LLP Investigates CSLT, VCRA, HXOH, OCDX; Globe Newswire ... duties relating to its sale to affiliates of American Securities LLC for $30.00 per share in cash. If you are a Hexion shareholder, click here to learn more about your rights and options .Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Quidel Corporation. Under the terms of the proposed agreement, Ortho shareholders ...
1/9/2022 Halper Sadeh LLP Investigates CSLT, VCRA, HXOH, OCDX; Shareholders are Encouraged to Contact the Firm forextv.com ... duties relating to its sale to affiliates of American Securities LLC for $30.00 per share in cash. If you are a Hexion shareholder, click here to learn more about your rights and options.Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Quidel Corporation. Under the terms of the proposed agreement, Ortho shareholders ...
1/7/2022 Genomics, MDx M&A Activity Exploded in 2021 Driven by COVID-19 Testing Tailwinds | Genomeweb genomeweb.com ... purchase of contract research organization PPD. The other deals of that magnitude included Danaher's $9.60 billion purchase of DNA manufacturer Aldevron; Illumina's consummation of its Grail merger; Quidel's last-minute Christmas shopping for Ortho Clinical Diagnostics ; PerkinElmer's reagent stashing with BioLegend; Roche's purchase of GenMark Diagnostics; DiaSorin's Luminex acquisition; and Tecan's play for Paramit. Another eight deals were worth between $500 million and $1 billion.Two trends were evident: Companies ...
1/7/2022 Quidel Preliminary Q4 Revenues Drop 21 Percent, Beat Estimates | 360Dx 360dx.com ... opening of our largest American immunoassay manufacturing facility to date in just nine months, to shipping nearly 77 million total rapid immunoassay tests in the quarter, to announcing our definitive agreement to acquire Ortho Clinical Diagnostics Holdings, Quidel emerged from a challenging year with the strongest portfolio of physical, financial, and intellectual assets in our history," Douglas Bryant, Quidel's president and CEO, said in a statement.In the quarter, Quidel ...
1/7/2022 Ortho Clinical Diagnostics Preliminary Q4 Revenues Rise 1 Percent | 360Dx 360dx.com NEW YORK ─ Ortho Clinical Diagnostics announced preliminary financial results for the fourth quarter after the close of the market on Thursday, saying it expects total revenues of between $520 million and $522 million, up approximately 1 percent year over year from $517 million.For the quarter ended Jan. 2, the Raritan, New Jersey-based company's core revenue, excluding SARS-CoV-2 sales, is expected to increase to between $508 ...
1/7/2022 Global Western Blotting Market (2021 to 2026) - Rising Demand for Personalized Medicine is Driving Growth Globe Newswire Western Blotting Market by Product, (Consumables (Antibody), Instrument (Electrophoresis, Blotting System, Imager (Fluorescent))), Application (Biomedical, Clinical Diagnostics ), End User (Research Institute, Hospital, Biopharma) - Global Forecast to 2026"The global western blotting market is projected to reach USD 1.4 billion by 2026 from USD 1.0 billion in 2021, at a CAGR of 6.7% during the forecast period.Technological advancements, increasing government funding in the field of biomedical research, growing demand for ...
1/7/2022 WisBusiness: the Podcast with Dr. Ulrich Broeckel, founder and CEO of RPRD Diagnostics wisbusiness.com ... He’s also a professor in the Departments of Pediatrics, Medicine and Physiology at the Medical College of Wisconsin, with over 20 years of experience working with genetics and genomics and 10 years in clinical diagnostics . The business is a clinical diagnostic lab focused on precision medicine, particularly in the field of pharmacogenetics. Its name stands for “right patient, right drug.”“Pharmacogenetics is really the science and the application ...